127 related articles for article (PubMed ID: 38629583)
1. Indicators of cure for women living after uterine and ovarian cancers: a population-based study.
Giudici F; De Paoli A; Toffolutti F; Guzzinati S; Francisci S; Bucchi L; Gatta G; Demuru E; Mallone S; Cin AD; Caldarella A; Cuccaro F; Migliore E; Gambino ML; Ravaioli A; Puppo A; Ferrante M; Carrozzi G; Stracci F; Musolino A; Gasparotti C; Cavallo R; Mazzucco W; Vitale MF; Cascone G; Ballotari P; Ferretti S; Mangone L; Rizzello RV; Sampietro G; Mian M; Boschetti L; Galasso R; Bella F; Piras D; Sessa A; Seghini P; Fanetti AC; Pinna P; De Angelis R; Serraino D; Maso LD; Working Group A
Am J Epidemiol; 2024 Apr; ():. PubMed ID: 38629583
[TBL] [Abstract][Full Text] [Related]
2. Italian cancer figures, report 2014: Prevalence and cure of cancer in Italy.
AIRTUM Working Group
Epidemiol Prev; 2014; 38(6 Suppl 1):1-122. PubMed ID: 25759295
[TBL] [Abstract][Full Text] [Related]
3. Cure indicators and prevalence by stage at diagnosis for breast and colorectal cancer patients: A population-based study in Italy.
Dal Maso L; Toffolutti F; De Paoli A; Giudici F; Francisci S; Bucchi L; Zorzi M; Fusco M; Caldarella A; Rossi S; De Angelis R; Botta L; Ravaioli A; Casella C; Musolino A; Vitale MF; Mangone L; Fanetti AC; Carpin E; Burgio Lo Monaco MG; Migliore E; Gambino ML; Ferrante M; Stracci F; Gasparotti C; Carrozzi G; Cavallo R; Mazzucco W; Ballotari P; Ferretti S; Sampietro G; Rizzello RV; Boschetti L; Cascone G; Mian M; Pesce MT; Piras D; Galasso R; Bella F; Seghini P; Pinna P; Crocetti E; Serraino D; Guzzinati S;
Int J Cancer; 2024 Jul; 155(2):270-281. PubMed ID: 38520231
[TBL] [Abstract][Full Text] [Related]
4. Complete prevalence and indicators of cancer cure: enhanced methods and validation in Italian population-based cancer registries.
Toffolutti F; Guzzinati S; De Paoli A; Francisci S; De Angelis R; Crocetti E; Botta L; Rossi S; Mallone S; Zorzi M; Manneschi G; Bidoli E; Ravaioli A; Cuccaro F; Migliore E; Puppo A; Ferrante M; Gasparotti C; Gambino M; Carrozzi G; Stracci F; Michiara M; Cavallo R; Mazzucco W; Fusco M; Ballotari P; Sampietro G; Ferretti S; Mangone L; Rizzello RV; Mian M; Cascone G; Boschetti L; Galasso R; Piras D; Pesce MT; Bella F; Seghini P; Fanetti AC; Pinna P; Serraino D; Dal Maso L;
Front Oncol; 2023; 13():1168325. PubMed ID: 37346072
[TBL] [Abstract][Full Text] [Related]
5. Long-term survival, prevalence, and cure of cancer: a population-based estimation for 818 902 Italian patients and 26 cancer types.
Dal Maso L; Guzzinati S; Buzzoni C; Capocaccia R; Serraino D; Caldarella A; Dei Tos AP; Falcini F; Autelitano M; Masanotti G; Ferretti S; Tisano F; Tirelli U; Crocetti E; De Angelis R; ; Virdone S; Zucchetto A; Gigli A; Francisci S; Baili P; Gatta G; Castaing M; Zanetti R; Contiero P; Bidoli E; Vercelli M; Michiara M; Federico M; Senatore G; Pannozzo F; Vicentini M; Bulatko A; Pirino DR; Gentilini M; Fusco M; Giacomin A; Fanetti AC; Cusimano R
Ann Oncol; 2014 Nov; 25(11):2251-2260. PubMed ID: 25149707
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of Malignant Cervical, Corpus Uteri and Ovarian Tumours - Current Data and Epidemiological Trends.
Waldmann A; Eisemann N; Katalinic A
Geburtshilfe Frauenheilkd; 2013 Feb; 73(2):123-129. PubMed ID: 24771908
[TBL] [Abstract][Full Text] [Related]
7. Italian cancer figures, report 2010: Cancer prevalence in Italy. Patients living with cancer, long-term survivors and cured patients.
AIRTUM Working Group
Epidemiol Prev; 2010; 34(5-6 Suppl 2):1-188. PubMed ID: 21220827
[TBL] [Abstract][Full Text] [Related]
8. Incidence and prevalence of drugs used for chronic diseases in survivors of adult-onset gynaecological cancer - A nationwide cohort study.
Bjørge T; Hjellvik V; Bjørge L; Dos-Santos-Silva I; Furu K; Kvåle R; Engeland A
BJOG; 2023 Jun; 130(7):770-778. PubMed ID: 36700296
[TBL] [Abstract][Full Text] [Related]
9. Cancer cure for 32 cancer types: results from the EUROCARE-5 study.
Dal Maso L; Panato C; Tavilla A; Guzzinati S; Serraino D; Mallone S; Botta L; Boussari O; Capocaccia R; Colonna M; Crocetti E; Dumas A; Dyba T; Franceschi S; Gatta G; Gigli A; Giusti F; Jooste V; Minicozzi P; Neamtiu L; Romain G; Zorzi M; De Angelis R; Francisci S;
Int J Epidemiol; 2020 Oct; 49(5):1517-1525. PubMed ID: 32984907
[TBL] [Abstract][Full Text] [Related]
10. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
11. Reliability of recording uterine cancer in death certification in France and age-specific proportions of deaths from cervix and corpus uteri.
Rogel A; Belot A; Suzan F; Bossard N; Boussac M; Arveux P; Buémi A; Colonna M; Danzon A; Ganry O; Guizard AV; Grosclaude P; Velten M; Jougla E; Iwaz J; Estève J; Chérié-Challine L; Remontet L
Cancer Epidemiol; 2011 Jun; 35(3):243-9. PubMed ID: 21106450
[TBL] [Abstract][Full Text] [Related]
12. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
13. Survival of gynecological cancers in Turkey: where are we at?
Gultekin M; Dundar S; Kucukyildiz I; Karaca MZ; Boztas G; Turan SH; Hacikamiloglu E; Keskinkilic B
J Gynecol Oncol; 2017 Nov; 28(6):e85. PubMed ID: 29027403
[TBL] [Abstract][Full Text] [Related]
14. Prognosis and cure of long-term cancer survivors: A population-based estimation.
Dal Maso L; Panato C; Guzzinati S; Serraino D; Francisci S; Botta L; Capocaccia R; Tavilla A; Gigli A; Crocetti E; Rugge M; Tagliabue G; Filiberti RA; Carrozzi G; Michiara M; Ferretti S; Cesaraccio R; Tumino R; Falcini F; Stracci F; Torrisi A; Mazzoleni G; Fusco M; Rosso S; Tisano F; Fanetti AC; Sini GM; Buzzoni C; De Angelis R;
Cancer Med; 2019 Aug; 8(9):4497-4507. PubMed ID: 31207165
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of gynecological cancers in Kamrup Urban District cancer registry.
Barman D; Sharma JD; Barmon D; Kataki AC; Sharma A; Kalita M
Indian J Cancer; 2017; 54(1):388-391. PubMed ID: 29199729
[TBL] [Abstract][Full Text] [Related]
17. Second cancer following cancer of the female genital system in Connecticut, 1935-82.
Curtis RE; Hoover RN; Kleinerman RA; Harvey EB
Natl Cancer Inst Monogr; 1985 Dec; 68():113-37. PubMed ID: 4088293
[TBL] [Abstract][Full Text] [Related]
18. Trends in the survival of patients diagnosed with cancer in female genital organs in the Nordic countries 1964-2003 followed up to the end of 2006.
Klint A; Tryggvadóttir L; Bray F; Gislum M; Hakulinen T; Storm HH; Engholm G
Acta Oncol; 2010 Jun; 49(5):632-43. PubMed ID: 20307243
[TBL] [Abstract][Full Text] [Related]
19. Cancer Cure and Consequences on Survivorship Care: Position Paper from the Italian Alliance Against Cancer (ACC) Survivorship Care Working Group.
Dal Maso L; Santoro A; Iannelli E; De Paoli P; Minoia C; Pinto M; Bertuzzi AF; Serraino D; De Angelis R; Trama A; Haupt R; Pravettoni G; Perrone M; De Lorenzo F; Tralongo P;
Cancer Manag Res; 2022; 14():3105-3118. PubMed ID: 36340999
[TBL] [Abstract][Full Text] [Related]
20. Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial.
Menon U; Gentry-Maharaj A; Burnell M; Ryan A; Kalsi JK; Singh N; Dawnay A; Fallowfield L; McGuire AJ; Campbell S; Skates SJ; Parmar M; Jacobs IJ
Health Technol Assess; 2023 May; ():1-81. PubMed ID: 37183782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
